Retrospective evaluation demonstrates short-term response and survival outcomes in dogs with immune-mediated thrombocytopenia, highlighting prognostic markers.
To describe the short-term response, early prognostic markers, and survival after treatment of canine immune-mediated thrombocytopenia (ITP) with human intravenous immunoglobulin (hIVIG) and methylprednisolone.
No takes yet. Share an insight, caveat, or question.
Zoia et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: